Generic Medicine Info
Pregnancy (prior to delivery); infants within 1-2 mth of birth; porphyria; severe renal or hepatic failure; blood disorders; hypersensitivity; SLE.
Special Precautions
Adequate hydration is necessary to reduce the risk of crystalluria. Discontinue immediately if rash appears. Renal or hepatic failure; asthma or history of allergy; elderly; G6PD deficiency; AIDS patients (especially those on trimethoprim).
Adverse Reactions
GI effects, hypersensitivity reactions, nephrotoxic reactions, blood disorders, hepatic disorders, CV effects, hypoglycaemia, hypothyroidism, neurological reactions, pseudomembranous colitis and kernicterus in premature neonates.
Potentially Fatal: Toxic epidermal necrolysis, Stevens-Johnson syndrome, anaphylaxis.
Drug Interactions
Potentiates effect of oral anticoagulants, methotrexate and phenytoin; possible failures of hormonal contraceptives; enhanced antidiabetic effect of sulfonylurea compounds; antagonism with PABA and its derivatives; associated with decrease in plasma-ciclosporin concentrations.
CIMS Class
ATC Classification
A07AB02 - phthalylsulfathiazole ; Belongs to the class of sulfonamide antiinfectives. Used in the treatment of intestinal infections.
Disclaimer: This information is independently developed by CIMS based on phthalylsulfathiazole from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in